Varenne, Olivier <br/><br/>
The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre study.  [electronic resource] 

 -  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology  Jan 2017 
 - 1614-1622 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1969-6213 
<br/><br/><label>Standard No.: </label>10.4244/EIJY15M12_02  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Drug-Eluting Stents<br/>Female<br/>Humans<br/>Male<br/>Myocardial Infarction--therapy<br/>Percutaneous Coronary Intervention--methods<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Prospective Studies<br/>Sirolimus--therapeutic use